burke & herbert - BHRB
BHRB
Close Chg Chg %
65.78 -0.82 -1.25%
Open Market
64.96
-0.82 (1.25%)
Volume: 49.15K
Last Updated:
Apr 10, 2026, 11:10 AM EDT
Company Overview: burke & herbert - BHRB
BHRB Key Data
| Open $65.57 | Day Range 64.76 - 66.23 |
| 52 Week Range 47.77 - 70.90 | Market Cap $968.29M |
| Shares Outstanding 15.03M | Public Float 13.25M |
| Beta 0.25 | Rev. Per Employee N/A |
| P/E Ratio 8.34 | EPS $7.76 |
| Yield 341.46% | Dividend $0.55 |
| EX-DIVIDEND DATE Feb 13, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 116.86K |
BHRB Performance
| 1 Week | 5.28% | ||
| 1 Month | 6.17% | ||
| 3 Months | 4.33% | ||
| 1 Year | 35.13% | ||
| 5 Years | 34.93% |
BHRB Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 74.50 | |
| Number of Ratings | 4 | Current Quarters Estimate | 1.263 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 7.395 | |
| Last Quarter’s Earnings | 1.865 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 7.72 | Next Fiscal Year Estimate | 9.098 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 4 | 4 | 4 |
| Mean Estimate | 1.26 | 2.17 | 7.40 | 9.10 |
| High Estimates | 2.08 | 2.56 | 8.19 | 9.89 |
| Low Estimate | 0.62 | 1.76 | 5.97 | 8.50 |
| Coefficient of Variance | 57.60 | 15.11 | 13.89 | 6.36 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 0 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Buy |
SEC Filings for Burke & Herbert - BHRB
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Burke & Herbert - BHRB
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 20, 2026 | Robert S. Tissue EVP, Financial Strategy | 52,290 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | David P. Boyle Chair & CEO; Director | 72,720 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Brad E. Ritchie EVP, Chief Lending Officer | 23,737 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Shannon B. Rowan EVP, Wealth Services | 5,060 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Lauren N. Kimlel EVP, Branch Banking | 3,718 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Danyl R. Freeman Chief Human Resources Officer | 4,053 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Joseph W. Hager Chief Operating Officer | 7,493 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Angela Zirk EVP, Chief Experience Officer | 3,012 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Jennifer Schmidt EVP, Chief Risk Officer | 4,472 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Robert V. Hintelmann Chief Credit Officer | 5,550 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 20, 2026 | Patrick Huffman SVP, Chief Accounting Officer | 1,495 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Sep 16, 2025 | Gary L. Hinkle Director | 248,559 | Open market or private purchase of non-derivative security Non-derivative transaction at $61.5 per share | 15,286,378.50 |
| Sep 16, 2025 | Gary L. Hinkle Director | 250,159 | Open market or private purchase of non-derivative security Non-derivative transaction at $61.7 per share | 15,434,810.30 |
| Jun 6, 2025 | Jose D. Riojas Director | 19,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $55.85 per share | 1,061,150.00 |
| May 8, 2025 | Shawn P. McLaughlin Director | 64,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $56.5 per share | 3,616,000.00 |
| May 1, 2025 | Samuel Laing Iii Hinson Director | 28,800 | Open market or private purchase of non-derivative security Non-derivative transaction at $53 per share | 1,526,400.00 |